Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers (Q36252676)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers |
scientific article |
Statements
1 reference
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers (English)
1 reference
D Gareth Evans
Matthew Burnell
Sue Philpott
Adam N Rosenthal
Mark Cline
Yang Pan
Ping-Cheng Yi
Charles E Wood
William C Dougall
1 reference